您的位置: 首页 > 2021年1月 第52卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

复方丹参滴丸联合阿托伐他汀治疗对伴有颈动脉粥样硬化短暂性脑缺血发作患者脑循环动力的影响

Effect of compound Danshen dripping pills combined with atorvastatin on cerebral circulation dynamics in patients with transient cerebral ischemia attacks carotid atherosclerosis

来源期刊: 广州医药 | 105-108 发布时间:2021-11-22 收稿时间:2025/11/13 18:13:42 阅读量:118
作者:
关键词:
复方丹参滴丸阿托伐他汀颈动脉粥样硬化短暂性脑缺血发作
Compound danshen drop pillsAtorvastatinCarotid atherosclerosisTransient ischemic attack
DOI:
10.3969/j.issn.1000-8535.2021.01.021
收稿时间:
2020-04-26 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨复方丹参滴丸联合阿托伐他汀治疗对伴有颈动脉粥样硬化短暂性脑缺血发作患者脑循环动力的影响。方法 将2017年12月—2018年12我院收治入院的98例伴有颈动脉粥样硬化短暂性脑缺血发作患者为研究对象,随机分为观察组(49例,给予复方丹参滴丸联合阿托伐他汀治疗)和对照组(49例,给予阿托伐他汀治疗)。观察对比治疗前及治疗后2组患者每日短暂性脑缺血发作频率及持续时间,血脂水平、血流变指标、粥样硬化斑块及斑块面积。结果 治疗前,两组患者每日短暂性脑缺血发作频率、持续时间、各项血脂水平、脑循环动力学指标IMT 及斑块面积相比,差异无统计学意义(P>0.05);治疗后,2组患者每日短暂性脑缺血发作频率、持续时间、各项血脂水平、脑循环动力学指标IMT 及斑块面积相比均有所改善,其中观察组患者每日短暂性脑缺血发作频率、持续时间、各项血脂水平、脑循环动力学指标IMT 及斑块面积相比优于对照组,差异有统计学意义(P<0.05)。结论 在伴有颈动脉粥样硬化短暂性脑缺血发作患者中采用复方丹参滴丸联合阿托伐他汀治疗效果确切,可有效降低伴有颈动脉粥样硬化的短暂性脑缺血发作患者发作频率及持续时间,同时可有效调节患者血脂水平,改善对脑循环动力学指标,值得临床推广普及。
Objective To investigate the effect of compound Danshen dripping pills combined with atorvastatin on cerebral circulation dynamics in patients with transient ischemic attack accompanied by carotid atherosclerosis. Methods A total of 98 patients with transient ischemic attack with carotid atherosclerosis admitted to our hospital from December 2017 to December 2018 were randomly divided into observation group (49 cases, receiving compound danshen drop pill combined with atorvastatin) and control group (49 cases, receiving atorvastatin), to observe and compare the frequency and duration of transient ischemic attack, blood lipid level, hemorheological indexes, atherosclerotic plaque and plaque area of the two groups before and after treatment. Results Before treatment, there was no significant difference in frequency, duration, blood lipid levels, IMT and plaque area between the two groups (P>0.05). After treatment, 2 groups of patients with transient ischemic attack daily frequency, duration, the lipid levels and cerebral circulation dynamics index IMT and plaque area were improved. Compared with observation group of patients with transient ischemic attack daily frequency, duration, the lipid levels and cerebral circulation dynamics index IMT and plaque area were better than control group, the differences were statistical significance (P<0.05). Conclusion Patients in associated with carotid atherosclerosis with transient ischemic attack using compound danshen dropping pill with atorvastatin therapy have good effects. This may effectively reduce frequency and duration in patients with transient ischemic attack associated with carotid atherosclerosis, regulate blood lipid levels at the same time, and improve the dynamics of cerebral circulation index. It is worthy of clinical popularization.
1、 洪雁,何云燕,杨元菊,等.复方丹参滴丸联合瑞舒伐他汀对伴颈动脉粥样硬化脑梗死患者调节性T细胞水平的影响[J]. 中草药,2017,48(8):1624-1628. 洪雁,何云燕,杨元菊,等.复方丹参滴丸联合瑞舒伐他汀对伴颈动脉粥样硬化脑梗死患者调节性T细胞水平的影响[J]. 中草药,2017,48(8):1624-1628.
2、 曹澜澜,徐士欣,张军平,等.复方丹参滴丸对短暂性脑缺血大鼠Nod样受体蛋白3/胱天蛋白酶1介导炎症反应的影响[J]. 中国临床药理学杂志,2019,35(2):27-31. 曹澜澜,徐士欣,张军平,等.复方丹参滴丸对短暂性脑缺血大鼠Nod样受体蛋白3/胱天蛋白酶1介导炎症反应的影响[J]. 中国临床药理学杂志,2019,35(2):27-31.
3、 肖铃. 复方丹参滴丸药理作用及临床应用的研究进展[J]. 世界中医药, 2015,10(7):1117-1119. 肖铃. 复方丹参滴丸药理作用及临床应用的研究进展[J]. 世界中医药, 2015,10(7):1117-1119.
4、 薛庆华,武能坤,李鹏,等.血栓通联合阿托伐他汀治疗对短暂性脑缺血发作患者颈动脉粥样硬化斑块、血脂及血流变的影响[J]. 中华中医药学刊,2018,36(4):1014-1018. 薛庆华,武能坤,李鹏,等.血栓通联合阿托伐他汀治疗对短暂性脑缺血发作患者颈动脉粥样硬化斑块、血脂及血流变的影响[J]. 中华中医药学刊,2018,36(4):1014-1018.
5、 彭子壮,卢晶晶,蔡海荣,等.短暂性脑缺血发作危险因素与中医体质的相关性研究[J]. 中西医结合心脑血管病杂志,2018,16(3):280-283. 彭子壮,卢晶晶,蔡海荣,等.短暂性脑缺血发作危险因素与中医体质的相关性研究[J]. 中西医结合心脑血管病杂志,2018,16(3):280-283.
6、 李鱼,江宗泽.纤溶酶与阿托伐他汀联合治疗短暂性脑缺血发作的临床研究[J]. 河北医学,2018,263(5):820-823. 李鱼,江宗泽.纤溶酶与阿托伐他汀联合治疗短暂性脑缺血发作的临床研究[J]. 河北医学,2018,263(5):820-823.
7、 吕祥龙,李婧.短暂性脑缺血发作后缺血性脑卒中的危险因素[J]. 临床神经病学杂志,2017,30(4):271-274. 吕祥龙,李婧.短暂性脑缺血发作后缺血性脑卒中的危险因素[J]. 临床神经病学杂志,2017,30(4):271-274.
8、 王光胜,王元伟,常春红,等.改良ABCD3评分对短暂性脑缺血发作患者脑卒中复发风险的评估价值[J]. 中华老年心脑血管病杂志,2017,19(7):689-693. 王光胜,王元伟,常春红,等.改良ABCD3评分对短暂性脑缺血发作患者脑卒中复发风险的评估价值[J]. 中华老年心脑血管病杂志,2017,19(7):689-693.
9、 罗羽慧,封杰,崔坤,等.马来酸依那普利叶酸片治疗短暂性脑缺血发作伴H型高血压的临床研究[J]. 中国药房,2017,28(2):222-224. 罗羽慧,封杰,崔坤,等.马来酸依那普利叶酸片治疗短暂性脑缺血发作伴H型高血压的临床研究[J]. 中国药房,2017,28(2):222-224.
10、 RATAJCZAK-TRETEL B,LAMBERT A T,JOHANSEN H,et al. Atrial fibrillation in cryptogenicstroke and transient ischaemic attack-The Nordic Atrial Fibrillation and Stroke(NOR-FIB)study:rationale and design[J]. Eur Stroke J,2019,4(2):172-180. RATAJCZAK-TRETEL B,LAMBERT A T,JOHANSEN H,et al. Atrial fibrillation in cryptogenicstroke and transient ischaemic attack-The Nordic Atrial Fibrillation and Stroke(NOR-FIB)study:rationale and design[J]. Eur Stroke J,2019,4(2):172-180.
11、 周妮,王颖.近年来中医治疗短暂性脑缺血发作研究概况[J].中医药临床杂志,2015(8):1083-1085. 周妮,王颖.近年来中医治疗短暂性脑缺血发作研究概况[J].中医药临床杂志,2015(8):1083-1085.
12、 中华神经科学会.各类脑血管疾病诊断要点[J]. 中华神经科杂志,1996,29(6):379. 中华神经科学会.各类脑血管疾病诊断要点[J]. 中华神经科杂志,1996,29(6):379.
13、 任晓梅, 李玲, 邱树卫,等. 前循环动脉粥样硬化性短暂性脑缺血发作的血管病变及预后影响因素[J]. 卒中与神经疾病, 2018, 25(6):28-32,41. 任晓梅, 李玲, 邱树卫,等. 前循环动脉粥样硬化性短暂性脑缺血发作的血管病变及预后影响因素[J]. 卒中与神经疾病, 2018, 25(6):28-32,41.
14、 BRAVATA D M,MYERS L J,REEVES M,et al. Processes of care associated with risk of mortality and recurrent stroke among patients with transient ischemic attack and nonsevere ischemic stroke[J]. JAMA Netw Open,2019,2(7):e196716. BRAVATA D M,MYERS L J,REEVES M,et al. Processes of care associated with risk of mortality and recurrent stroke among patients with transient ischemic attack and nonsevere ischemic stroke[J]. JAMA Netw Open,2019,2(7):e196716.
15、 SAFANELLI J,VIEIRA LGDR,ARAUJO T,et al. The cost of stroke in apublic hospital in Brazil:a one-year prospective study[J]. Arq Neuropsiquiatr,2019,77(6):404-411. SAFANELLI J,VIEIRA LGDR,ARAUJO T,et al. The cost of stroke in apublic hospital in Brazil:a one-year prospective study[J]. Arq Neuropsiquiatr,2019,77(6):404-411.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录